drugset / Trial / NCT02761993

Safety, Efficacy and Treatment Regimen Study of ST266 in Subjects With Moderate to Severe Periodontitis

NCT02761993 ↗

Phase 2 Completed 151 enrolled Noveome Biotherapeutics
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether ST266 will reduce pocket depth (PD) as an adjunctive to scaling and root planing (SRP) in subjects with moderate to severe periodontal disease.

Timeline

Start
2016-04
Primary completion
2017-10
Completion
2017-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator ST266 Protein / enzyme biologic 0.02 ml Topical

Indications